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PHeart Rhythm Disorders
Inappropriate Implantable
Cardioverter-Defibrillator Shocks
Incidence, Predictors, and Impact on Mortality
Johannes B. van Rees, MD,* C. Jan Willem Borleffs, MD,* Miha´ly K. de Bie, MD,*
Theo Stijnen, PHD,† Lieselot van Erven, MD, PHD,* Jeroen J. Bax, MD, PHD,*
Martin J. Schalij, MD, PHD*
Leiden, the Netherlands
Objectives The purpose of this study was to assess the incidence, predictors, and outcome of inappropriate shocks in im-
plantable cardioverter-defibrillator (ICD) patients.
Background Despite the benefits of ICD therapy, inappropriate defibrillator shocks continue to be a significant drawback. The
prognostic importance of inappropriate shocks outside the setting of a clinical trial remains unclear.
Methods From 1996 to 2006, all recipients of defibrillator devices equipped with intracardiac electrogram storage were
included in the current analysis and clinically assessed at implantation. During follow-up, the occurrence of inap-
propriate ICD shocks and all-cause mortality was noted.
Results A total of 1,544 ICD patients (79% male, age 61  13 years) were included in the analysis. During the follow-up
period of 41  18 months, 13% experienced 1 inappropriate shocks. The cumulative incidence steadily in-
creased to 18% at 5-year follow-up. Independent predictors of the occurrence of inappropriate shocks included a
history of atrial fibrillation (hazard ratio [HR]: 2.0, p  0.01) and age younger than 70 years (HR: 1.8, p  0.01).
Experiencing a single inappropriate shock resulted in an increased risk of all-cause mortality (HR: 1.6, p  0.01).
Mortality risk increased with every subsequent shock, up to an HR of 3.7 after 5 inappropriate shocks.
Conclusions In a large cohort of ICD patients, inappropriate shocks were common. The most important finding is the associa-
tion between inappropriate shocks and mortality, independent of interim appropriate shocks. (J Am Coll
Cardiol 2011;57:556–62) © 2011 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.06.059m
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tentricular tachycardia (VT), deteriorating to ventricular
brillation (VF) is responsible for an estimated one third of
ll cardiovascular mortality worldwide (1–3). Several impor-
ant clinical trials have shown that the implantable
ardioverter-defibrillator (ICD) provides a substantial and
ignificant reduction in mortality in survivors of sudden
ardiac arrest and high-risk patients with cardiovascular
isease (4–9). Despite proven survival benefits, ICD treat-
ent still has drawbacks, one of the most important being
hocks delivered for causes other than potentially life-
hreatening VT or VF. These inappropriate shocks are
ainful, psychologically disturbing, and potentially arrhyth-
rom the *Department of Cardiology, Leiden University Medical Center, Leiden, the
etherlands; and the †Department of Medical Statistics, Leiden University Medical
enter, Leiden, the Netherlands. Prof. Bax has received research grants from GE
ealthcare, Bristol-Myers Squibb Medical Imaging, St. Jude, Medtronic, Boston
cientific, Biotronik, and Edwards Lifesciences. Prof. Schalij has received research
rants from Biotronik, Medtronic, and Boston Scientific. All other authors have
eported that they have no relationships to disclose.t
Manuscript received November 24, 2009; revised manuscript received June 11,
010, accepted June 14, 2010.ogenic (10–13). Recently, a subgroup analysis of 2 major
CD clinical trials reported on the prognosis of ICD shocks
nd raised concern by establishing an association between
nappropriate shocks and increased mortality (14,15). How-
ver, extrapolating these results to ICD recipients into
veryday or routine clinical practice is difficult because these
linical trials comprised a selected population. Therefore, we
nalyzed a large population of ICD patients with long-term
ollow-up outside the setting of a clinical trial to evaluate the
ccurrence of inappropriate ICD shocks, to identify poten-
ial predictive parameters for inappropriate shocks, and to
ssess the impact of inappropriate shocks on long-term
utcome.
ethods
atient population. Since 1996, all patients who received
n ICD at the Leiden University Medical Center were
ecorded in the departmental Cardiology Information Sys-
em (EPD-vision, Leiden University Medical Center). For
he current analysis, all ICDs implanted up to 2006 were
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February 1, 2011:556–62 Inappropriate ICD Shocksncluded to ensure a minimum in follow-up duration.
ligibility for ICD treatment was determined in accordance
ith the international guidelines and included patients with
ustained VT and patients with a severely depressed left
entricular ejection fraction, regardless of previous ventric-
lar arrhythmia (16–18). As a result of advancing guide-
ines, the eligibility has changed over time.
To retrieve accurate information about the origin and
lassification (i.e., appropriate vs. inappropriate) of ICD
hocks, only recipients of ICDs equipped with intracardiac
lectrogram storage were included in the current analysis.
aseline characteristics were collected to identify potential
redictors of inappropriate shocks. In addition, the effect of
nappropriate shocks on mortality was assessed.
evice implantation and programming. All defibrillator
ystems were implanted in the pectoral region. During the
mplant procedure, testing of sensing and pacing threshold and
efibrillation threshold was performed. The systems used were
anufactured by Biotronik (Berlin, Germany), Medtronic
Minneapolis, Minnesota), Boston Scientific (Natick, Massa-
husetts), and St. Jude Medical (St. Paul, Minnesota).
Defibrillators were programmed as follows: ventricular
rrhythmia faster than 150 beats/min was monitored by the
evice without consequent defibrillator therapy (zone 1). Ven-
ricular arrhythmias faster than 188 beats/min were initially
ttempted to be terminated with 2 bursts of anti-tachycardia
acing and, after continuation of the arrhythmia, with defibril-
ator shocks (zone 2). In the case of a ventricular arrhythmia
aster than 210 beats/min, device shocks were the initial
herapy (zone 3). Furthermore, atrial arrhythmia detection was
et to 170 beats/min with supraventricular tachycardia dis-
riminators enabled. In all devices, stability and sudden onset
lgorithms were activated to reduce the occurrence of inappro-
riate shocks (19). Moreover, additional discriminators were
ctivated in dual-chamber ICDs and cardiac resynchronization
herapy defibrillators (20,21). Settings were adapted only when
linically indicated (i.e., hemodynamic well-tolerated VT at
igh rate, VT in the monitor zone).
ollow-up. In the Dutch health care system, the implant-
ng center is responsible for the device follow-up, which is
erformed every 3 to 6 months after implantation. At every
ollow-up, device storage was checked for delivered therapy
appropriate/inappropriate). Adjudication of the delivered
herapy was performed by a trained electrophysiologist.
An inappropriate shock was defined as an episode,
tarting with a shock not delivered for VT or VF and ending
f sinus rhythm was redetected by the ICD. Consequently,
t was possible that multiple inappropriate shocks occur
ithin 1 episode. If a subsequent episode started within 5
in after the previous episode ended, it was not considered
s a new episode. Furthermore, the cause of an inappropri-
te shock was categorized into supraventricular tachycardia
including atrial fibrillation [AF]), sinus tachycardia, or
bnormal sensing.
Patients with missing data for more than 6 months were
onsidered lost to follow-up. 1tatistical analysis. Continuous
ariables were presented as mean
SD and categorical variables as
umber and percentage. Cumu-
ative event rates were calculated
y using the Kaplan-Meier
ethod and log-rank test, in
hich patient death and device
eplacement were considered
ensoring events. Causes of inap-
ropriate shocks for the different
evice types were compared us-
ng the chi-square test. Predic-
ors of inappropriate shocks were
etermined by the method of Cox proportional hazards
egression. First, univariate analysis was performed, con-
aining all baseline variables and interim appropriate shocks.
ubsequently, all variables with a p value 0.10 were
ncluded in the multivariate analysis. A p value 0.25 was
onsidered as statistically significant for the multivariate
egression. To examine differences in the occurrence of
nappropriate shocks per time span of ICD implantations,
atients were divided into 2 groups by the median calendar
ear of ICD implantations. A log-rank test was used to
ompare the cumulative event rates between both groups.
The relationship between inappropriate shocks and all-
ause mortality was assessed using a Cox proportional
azard model with first inappropriate shock or multiple
nappropriate shocks (5 shocks) as a time-dependent
ovariate, adjusting for commonly used predictors of all-
ause mortality (history of AF, age older than 70 years [22],
ew York Heart Association (NYHA) functional class
igher than II, renal clearance 90 ml/min [determined
ith the Cockroft-Gault formula] [23], QRS duration
120 ms, use of -blockers [22], and interim appropriate
hocks [15]).
Interim appropriate shocks were defined as appropriate
CD shocks before an inappropriate ICD shock and con-
idered time-dependent covariates in analyses for prediction
f inappropriate shocks as well as for prediction of all-cause
ortality. The calculated relationship was presented as a
azard ratio (HR) with a 95% confidence interval (CI).
The statistical software program SPSS version 16.0
SPSS, Inc., Chicago, Illinois) was used for statistical
nalysis. A p value 0.05 was considered significant, with
he exception of multivariate analyses.
esults
atient population. From 1996 to 2006, 1,658 patients
eceived an ICD system with intracardiac electrogram tech-
ology according to the international guidelines (16–18).
ne hundred fourteen patients (7%) were lost to follow-up.
he remaining 1,544 patients (93%) constituted the patient
opulation. Of these patients (79% men, average age 61 
Abbreviations
and Acronyms
AF  atrial fibrillation
CI  confidence interval
HR  hazard ratio
ICD  implantable
cardioverter-defibrillator
NYHA  New York Heart
Association
VF  ventricular fibrillation
VT  ventricular
tachycardia3 years), 56% received an ICD for primary prevention and
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Inappropriate ICD Shocks February 1, 2011:556–624% had ischemic heart disease. Baseline patient character-
stics are summarized in Table 1.
ncidence of inappropriate shocks. During the follow-up
eriod of 41  18 months, 204 of 1,544 patients (13%)
xperienced a total of 665 inappropriate ICD shocks. The
verage time from implantation to first inappropriate shock
as 17  16 months. The cumulative event rate for first
nappropriate shocks was 7% (95% CI: 6% to 9%) at 1 year,
3% (95% CI: 11% to 14%) at 3 years, and 18% (95% CI:
5% to 20%) at 5 years (Fig. 1). A second inappropriate
hock was experienced by 73 of 204 patients (36%) with an
verage time from first to second shock of 11  11 months.
he cumulative event rate for a second inappropriate shock
as 28% (95% CI: 22% to 34%) at 1-year follow-up, 49%
95% CI: 40% to 58%) at 3-year follow-up, and 55% (95%
I: 44% to 66%) at 5-year follow-up (Fig. 2).
redictors of inappropriate shocks. To determine specific
linical parameters predicting the occurrence of inappropri-
te device discharges, the univariate Cox model disclosed
hat age younger than 70 years (HR: 1.7, 95% CI: 1.1 to 2.3;
 0.01), history of AF (HR: 2.0, 95% CI: 1.5 to 2.7; p 
.01), nonischemic heart disease (HR: 1.3, 95% CI: 1.0 to
.8; p  0.04), nonuse of statins (HR: 1.4, 95% CI: 1.0 to
.8; p  0.03), and interim appropriate shocks (HR: 1.6,
5% CI: 1.0 to 2.7; p  0.04) were independent predictors
aseline Characteristics ofti nt Popul tion (n  1,544)Table 1 B seline Characteristics ofPatient Population (n  1,544)
Clinical parameters
Age (yrs) 61 13
Male 1,220 (79)
Primary prevention 865 (56)
Ischemic heart disease 988 (64)
Left ventricular ejection
fraction
35 16%
QRS duration (ms) 125 35
NYHA functional class III or IV 510 (33)
History of AF 355 (23)
History of smoking 818 (53)
Diabetes 293 (19)
Medication
Beta-blockers (without
sotalol)
787 (51)
Sotalol 216 (14)
Statins 880 (57)
Diuretics 942 (61)
ACE inhibitors/AT antagonists 1,112 (72)
Ca antagonists 154 (10)
Amiodarone 309 (20)
Devices
Single-chamber ICD 188 (12)
Dual-chamber ICD 819 (53)
CRT-D 537 (35)
alues shown are mean  SD or n (%).
ACE  angiotensin-converting enzyme; AF  atrial fibrillation; AT  angiotensin; CRT-D 
ardiac resynchronization therapy defibrillator; ICD implantable cardioverter-defibrillator; NYHA
ew York Heart Association.f inappropriate shocks (Table 2). By multivariate analysis,ge younger than 70 years (HR: 1.8, 95% CI: 1.3 to 2.5; p 
.01), history of AF (HR: 2.0, 95% CI: 1.5 to 2.7; p 
.01), no statin use (HR: 1.3, 95% CI: 1.0 to 1.7; p 0.10),
nd interim appropriate shocks (HR: 1.6, 95% CI: 1.0 to
.6; p  0.06) were predictors of the occurrence of inap-
ropriate shocks.
eriod of ICD implantation. To explore whether differ-
nces over time could be observed in the occurrence of
nappropriate shocks, 2 ICD patient groups were designated
ccording to the median of calendar years of ICD implan-
ations (May 2004). The first group underwent ICD im-
lantation from 1996 to May 2004 and comprised 772
atients. The cumulative event rate for first inappropriate
hock was 7% (95% CI: 5% to 9%) at 1 year, 10% (95% CI:
% to 12%) at 2 years, and 11% (95% CI: 9% to 14%) at 3
ears. The second group consisted of 772 patients who
eceived an ICD system from May 2004 to 2006. The
umulative event rate for first inappropriate shock was 8%
95% CI: 6% to 10%) at 1 year, 12% (95% CI: 9% to 14%)
t 2 years, and 14% (95% CI: 11% to 16%) at 3 years (Fig. 3).
Figure 2 Second Inappropriate Device Shock
Kaplan-Meier curve for the occurrence of second inappropriate implantable
cardioverter-defibrillator (ICD) shock received after the first inappropriate ICD
shock.
Figure 1 First Inappropriate Device Shock
Kaplan-Meier curve for the occurrence of first inappropriate
implantable cardioverter-defibrillator shock.
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February 1, 2011:556–62 Inappropriate ICD ShocksIn multivariate risk analysis, adjusted for baseline and
nterim variables (history of AF, age younger than 70 years,
o statin use, and interim appropriate shocks), patients who
eceived an ICD after May 2004, compared with before
ay 2004, tended to experience more inappropriate shocks
HR: 1.3, 95% CI: 1.0 to 1.8; p  0.05).
auses and differences between device types. The main
ause of inappropriate shocks was misdiagnosis of supraven-
ricular tachycardia, occurring in 155 of the 204 patients
76%). The mean ventricular cycle length at the time of a
atient’s first inappropriate shock for supraventricular tachy-
ardia was 299  39 ms and occurred predominantly in
CD program zone 2 (60%).
As can be seen in Table 3, comparison per device type did
ot show significant differences in the occurrence of inap-
ropriate shocks. However, the cause of inappropriate
hocks did differ between device types. Patients with a
ingle-chamber ICD received significantly more shocks
esulting from misdiagnosis of sinus tachycardia than pa-
Predictors of >1 Inappropriate ShocksTable 2 Predictors of >1 Inappropriate Sho
Univar
HR 95% CI
Female 0.8 0.6–1.2
Age 70 yrs 1.7 1.1–2.3
History of AF 2.0 1.5–2.7
History of smoking 1.2 0.9–1.6
Secondary indication for ICD 1.1 0.8–1.5
Nonischemic heart disease 1.3 1.0–1.8
No statins at baseline 1.4 1.0–1.8
Beta-blocker 0.8 0.6–1.1
NYHA functional class III to IV 1.0 0.7–1.3
Interim appropriate shocks 1.6 1.0–2.7
*Variable was included in multivariate analysis.
CI  confidence interval; HR  hazard ratio; other abbreviations as
Figure 3 First Inappropriate Shock
Comparing Time Periods of ICD Implantation
Kaplan-Meier curve for the occurrence of first inappropriate implantable car-
dioverter-defibrillator (ICD) shock in patients who received an ICD before
May 2004 (solid line) and in patients who received an ICD after May 2004
(dashed line).4ients with a dual-chamber ICD (24% vs. 8%, p  0.02).
urthermore, patients with cardiac resynchronization ther-
py with a defibrillator tended to experience more inappro-
riate discharges due to abnormal sensing than ICD recip-
ents with a single-chamber ICD (15% vs. 8%, p  0.28).
ffect of inappropriate shocks on survival. A total of 298
atients (19%) died during the study follow-up. Compared
ith patients without inappropriate shocks, the occurrence
f the first inappropriate shock tended to increase the risk of
ll-cause mortality (HR: 1.4, 95% CI: 1.0 to 2.0; p  0.07).
djustment for potential confounders (history of AF, age
lder than 70 years, NYHA functional class higher than II,
enal clearance 90 ml/min, QRS duration 120 ms,
eta-blocker use, and interim appropriate shocks) demon-
trated that the occurrence of an initial inappropriate shock
as related to a 60% increase in risk of mortality (HR: 1.6,
5% CI: 1.1 to 2.3; p  0.01). Moreover, adjusted time-
ependent mortality risk of subsequent inappropriate shocks
ad an HR of 1.4 (95% CI: 1.2 to 1.7, p  0.01) per
dditional shock, up to an HR of 3.7 after experiencing 5
nappropriate shocks (Table 4).
iscussion
he main findings of the current study on the incidence,
redictors, and outcome of inappropriate shocks can be sum-
arized as follows: 1) the cumulative incidence of inappropri-
te shocks was 7% at 1-year follow-up, 13% at 3-year follow-
p, and 18% at 5-year follow-up; 2) misdiagnosis of
upraventricular tachycardia was the leading cause (76%) of
nappropriate shocks; 3) age younger than 70 years,
istory of AF, no statin use, and interim appropriate shocks
ere predictors of inappropriate shocks; and 4) inappropri-
te shocks were associated with a higher risk of all-cause
ortality.
ncidence. In major randomized clinical trials, the occurrence
f inappropriate ICD therapy (i.e., anti-tachycardia pacing and
hocks) is well assessed, ranging from 10% to 24% over 20 to
Multivariate
p Value HR 95% CI p Value
0.34
0.01* 1.8 1.3–2.5 0.01
0.01* 2.0 1.5–2.7 0.01
0.32
0.48
0.04*
0.03* 1.3 1.0–1.7 0.09
0.22*
0.96
0.04* 1.6 1.0–2.6 0.06
e 1.cks
iate5 months of follow-up (24). However, lower incidences were
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Inappropriate ICD Shocks February 1, 2011:556–62eported when assessing inappropriate shocks only, such as 9%
n the AVID (Antiarrhythmics versus Implantable Defibrilla-
ors) trial (15) and 11.5% in the MADIT II (Multicenter
utomatic Defibrillator Implantation Trial II) (25), both
eported during 2-year follow-up. The current analysis dem-
nstrated a comparable cumulative event rate of 10% at 2-year
ollow-up and showed that this incidence steadily increased to
8% at 5-year follow-up. In addition, more than one-half of
he patients who received a single inappropriate shock experi-
nced another one within the 5-year follow-up.
redictors. Because more than one-half of all inappropri-
te shocks are due to misdiagnosis of AF, several studies
ound a history of AF was the most significant baseline
linical predictor of inappropriate shocks (15,26–31). Then
gain, these studies showed less consistency in identifying
ther predictors. For instance, Hreybe et al. (27) demon-
trated patients with severe symptomatic heart failure
NYHA functional classes III and IV) to be at increased risk
f inappropriate shocks, whereas Nanthakumar et al. (28)
emonstrated NYHA functional class I as an independent
redictor of inappropriate shocks. Furthermore, other pre-
ictors included the absence of coronary artery disease, use
f -blockers, ICD device type, history of smoking, no
Causes of Inappropriate ShocksTable 3 Causes of Inappropriate Shocks
Total
(n  1,544)
Patients with 1 inappropriate shock 204 (13)
Rhythm misdiagnosis
Supraventricular tachycardia 155 (76)
AF 92 (45)
Other than AF 63 (31)
Abnormal sensing 25 (12)
Sinus tachycardia 22 (11)
Unclassified 2 (1)
Values shown are n (%).
Abbreviations as in Table 1.
Predictors of All-Cause MortalityTable 4 Predictors of All-Cause Mortality
Un
HR 95%
Baseline variables
History of atrial fibrillation* 1.3 1.0–
Age 70 yrs* 2.7 2.2–
NYHA functional class II* 2.0 1.6–
Renal clearance 90 ml/min* 2.7 2.0–
QRS duration 120 ms* 2.0 1.6–
No use of beta-blockers* 1.3 1.0–
Interim events
Inappropriate shock 1.4 1.0–
Per inappropriate shocks (5)† 1.3 1.1–
Interim appropriate shocks* 2.5 1.9–
*Adjusted in multivariate analysis for single inappropriate shock. †I
appropriate shocks.
Abbreviations as in Tables 1 and 2.tatin use, younger age, and increased diastolic blood pres-
ure (15,26,27,29,31).
In the current study, multivariate analysis demonstrated
hat ICD recipients with a history of AF have a significantly
igher risk of inappropriate shocks (HR: 2.0, p  0.01).
dditionally, the present study showed that age younger
han 70 years independently predicted the occurrence of
nappropriate shocks (HR: 1.8, p  0.01). Most likely, this
s due to the fact that 23% of all inappropriate shocks were
aused by abnormal sensing and sinus tachycardia, both
ssociated with younger age (32).
The large cohort and long follow-up assessed in the
urrent analysis might provide more accurate identification
f predictors of inappropriate shocks than that proposed in
revious studies.
revention of inappropriate shock over time. Ever since
he first implantation, ICDs are under constant development
o improve treatment of tachyarrhythmias and decrease adverse
vents. Advanced algorithms, multiple sensing leads, and
mproved device programming should reduce the occurrence of
nappropriate shock (19–21). Interestingly, the current study
id not confirm this theory. Patients who received their ICD
ystem after May 2004, compared with before May 2004, did
le-Chamber ICD
(n  188)
Dual-Chamber ICD
(n  819)
CRT-D
(n  537)
29 (15) 122 (15) 53 (10)
19 (65) 96 (79) 40 (75)
14 (48) 55 (45) 23 (43)
5 (17) 41 (34) 17 (32)
2 (8) 15 (12) 8 (15)
7 (24) 10 (8) 5 (10)
1 (3) 1 (1) 0 (0)
e Multivariate
p Value HR 95% CI p Value
0.11 1.4 1.0–1.7 0.01
0.01 1.9 1.5–2.5 0.01
0.01 1.5 1.1–1.9 0.03
0.01 1.7 1.2–2.4 0.02
0.01 1.4 1.1–1.8 0.02
0.01
0.07 1.6 1.1–2.3 0.01
0.01 1.4 1.2–1.7 0.01
0.01 1.6 1.2–2.1 0.01
variate analysis, adjusted for all baseline variables and for interimSingivariat
CI
1.7
3.4
1.5
3.7
2.5
1.7
2.0
1.6
3.3
n multi
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February 1, 2011:556–62 Inappropriate ICD Shocksot experience fewer inappropriate shocks (Fig. 3). In addition,
ultivariate analysis, adjusted for baseline and interim vari-
bles, even showed that these patients were at increased risk of
xperiencing inappropriate shocks. The most plausible expla-
ation for this paradox is found within the evolving guidelines,
hich intermittently change ICD patient population from
ostly secondary prevention patients to mostly primary pre-
ention patients. In general, primary prevention patients are in
oor cardiac condition (33), which could result in higher risk
nd prevalence of AF—the strongest predictor of the occur-
ence of inappropriate shocks. Hence, the increasing number
f primary prevention patients could downgrade the effect of
dvanced ICD technology in reducing the occurrence of
nappropriate shock.
ingle-chamber ICDs versus dual-chamber ICDs versus
ardiac resynchronization therapy defibrillators. With su-
raventricular arrhythmias as the principal cause of inappro-
riate shocks, one might hypothesize that additional sensing
nformation would improve discrimination between supraven-
ricular tachyarrhythmias and ventricular tachyarrhythmias to
revent inappropriate therapy. Therefore, in theory, dual-
hamber ICDs should perform better than single-chamber
CDs. However, in the literature, there are doubts regarding
he performance of devices with extra sensing/pacing leads
ompared with single-chamber ICDs. Theuns et al. (34)
erformed a prospective, randomized study to evaluate the
erformance of tachyarrhythmia detection algorithms in
ingle- and dual-chamber ICDs, but did not find a significant
eduction in the number of inappropriate arrhythmia classifi-
ations. Other studies found similar results (20,35,36). In
ontrast, a randomized trial conducted by Friedman et al. (37)
emonstrated a small but significant reduction of inappropriate
upraventricular tachyarrhythmias detection (8.6%) when using
ptimized programmed dual-chamber ICDs compared with
ingle-chamber ICDs. These findings were supported by
oundarraj et al. (29).
In the present study, no significant differences were
bserved in the incidence of inappropriate shocks when
omparing the 3 different device types.
ong-term outcome. Recent subgroup analysis of the
ADIT II and the SCD-HeFT (Sudden Cardiac Death In
eart Failure Trial) found an association between increased
ortality risk and ICD shocks, irrespective of appropriate-
ess (14,15). For appropriate shocks, this association is
xplicable because patients who receive appropriate shocks
lso have VT or VF due to progressively deteriorating
ardiac condition. In contrast, it was unforeseen that this
ssociation also applied to inappropriate shocks.
The present study confirmed this finding in routine
linical practice, outside the setting of a clinical trial, by
emonstrating a significant correlation between inappropri-
te shocks and death. Moreover, the risk of all-cause
ortality increased per delivered inappropriate shock; up to
n HR of 3.7 after experiencing 5 inappropriate shocks.
One might postulate different explanations for the in-reased risk of death, including: 1) myocardial injury result-
mng in deterioration of left ventricular ejection fraction; 2)
ncreased anxiety and depression associated with increased
ortality; and 3) the indirect result of AF, being the leading
echanism for inappropriate shocks and also associated
ith an increased risk of mortality (38–40). From the
urrent study, it is difficult to favor one explanation over
nother. However, various studies have supported the first
xplanation because they found increased markers for myo-
ardial damage after uncomplicated ICD testing at implan-
ation, implying cardiac tissue damage due to these high-
oltage electrical discharges (38,41,42).
When comparing the results of the subgroup analysis
f the MADIT II and SCD-HeFT with the current
tudy, a notable difference was seen in the risk of all-
ause mortality after experiencing an inappropriate shock
HR: 2.2 vs. HR: 2.0 vs. HR: 1.6, respectively). This
ifference could be explained if one assumed that (inap-
ropriate) ICD shocks indeed cause myocardial tissue
njury. In addition, ICD patients with poor cardiac
ondition and left ventricular function have less reserve to
ithstand extra cardiac damage. Therefore, inappropriate
hocks will have more adverse consequences in a popu-
ation with reduced cardiac function, as assessed in the
ADIT II and SCD-HeFT (5,14).
Overall, it remains difficult to state that the higher risk of
eath was indeed caused by inappropriate ICD shocks, but
o far, 3 large independent studies demonstrated an adverse
elationship between ICD shocks and patient survival.
tudy limitations. The current study used prospectively
ollected data from a single-center ICD registry. Because
CDs were implanted over a 10-year period, evolving and
xpanding guidelines for the implantation of ICDs, device
rogramming, and pharmacological treatment of arrhyth-
ias could have created a heterogeneous population. Fur-
hermore, we attempted to control for potential confounders
sing multivariate statistical with time-dependent covariate
nalysis. However, the influence of potentially included
nknown confounders could not be ruled out.
onclusions
he current study demonstrates that in an ICD patient cohort,
utside the setting of a clinical trial, inappropriate shocks occur
n 13% of ICD recipients, mainly due to misdiagnosis of
upraventricular tachycardia. Clinical predictors of inappropri-
te shocks were younger age, history of AF, no statin use, and
nterim appropriate shocks. Finally, inappropriate shocks were
ssociated with a higher risk of all-cause mortality, which
ncreased per delivered inappropriate shock and was indepen-
ent of interim appropriate shocks.
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